정맥내 장비 시장 : 제품 유형별, 최종사용자별 - 세계 기회 분석과 산업 예측(2023-2032년)

According to a new report published by Allied Market Research, titled, "Intravenous Equipment Market," The intravenous equipment market was valued at $15.0 billion in 2022, and is estimated to reach $26.7 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.

Intravenous (IV) equipment refers to the tools and devices used in intravenous therapy, a medical procedure that involves delivering fluids, medications, or nutrients directly into a patient's bloodstream through a vein. IV therapy is commonly used for various purposes, including hydration, administering medications, blood transfusions and nutritional support. Examples of intravenous equipment include needles or catheters that are inserted into a vein to create access, flexible tubing's that connects the IV bag or container to the patient and infusion pumps are electronic devices that control and regulate the flow rate, ensuring precise delivery.

The major factors driving the growth of the intravenous equipment market are the increase in number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV equipment technology. The demand for IV therapy is driven by the rising incidence of chronic diseases such cancer, diabetes, cardiovascular problems, and infectious diseases. Intravenous administration allows for the direct and efficient delivery of medications, fluids and nutrition, making it a crucial treatment method for patients with chronic conditions. In addition, world's population is experiencing a significant demographic shift, with a rapidly growing elderly population. The elderly people are more prone to developing chronic illnesses, which necessitate frequent hospital stays and medical treatment. IV therapy plays a vital role in providing supportive care to geriatric patients. Thus, the increasing geriatric population is contributing to the growth of the intravenous equipment market.

Further, continuous advancements in intravenous equipment technology have improved safety, precision and ease of use in administering intravenous therapy. Innovations such as smart infusion pumps, integrated connectivity solutions and needleless IV systems have enhanced the efficiency and accuracy of drug delivery, reduced the risk of medication errors and improved patient outcomes. Furthermore, growing awareness about the benefits of intravenous therapy, such as faster drug absorption, precise medication delivery and improved patient compliance, has increased among healthcare professionals and patients. Thus, more medical practitioners are incorporating IV therapy into their treatment plans, leading to a higher demand for intravenous equipment.

Additionally, as many nations invest more funds in enhancing healthcare infrastructure and boosting access to high-quality medical services, healthcare spending keeps rising. This increased healthcare spending encompasses the procurement of essential medical equipment, including IV equipment, to meet the growing demand for advanced patient care, thereby propelling the market growth. In addition, emergency departments and critical care units frequently rely on IV therapy to stabilize patients quickly and administer life-saving medications or fluids. The rising number of emergency care cases and trauma incidents worldwide has significantly contributed to the demand for IV equipment in these settings. IV equipment plays a vital role in delivering essential treatments promptly and efficiently, ensuring optimal patient outcomes in critical care scenarios.

The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors, and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global intravenous equipment market are Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategy such as product approval and acquisition to expand their product portfolio.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intravenous equipment market analysis from 2022 to 2032 to identify the prevailing intravenous equipment market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the intravenous equipment market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global intravenous equipment market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Product Type

• IV catheters
• Infusion pumps
• Administration sets
  • Type of set
  • Solution administration sets
  • Blood administration sets.
• Needleless connectors
• Others

By End User

• Hospitals and clinics
• Homecare settings
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• AngioDynamics, Inc.
• Becton, Dickinson and Company
• Vygon
• 3M Company
• Terumo Corporation
• Poly Medicure Ltd.
• B. Braun SE
• ICU Medical, Inc.
• Baxter International Inc.
• Teleflex Incorporated.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. High bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. Moderate threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. High bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Technological advancements in intravenous equipment
    • 3.4.1.2. Growing number of surgical procedures
    • 3.4.1.3. Growing prevalence of chronic diseases

• 3.4.2. Restraints
  • 3.4.2.1. Stringent regulatory requirements

• 3.4.3. Opportunities
  • 3.4.3.1. Growth opportunities in emerging markets

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. IV catheters
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Infusion pumps
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Administration sets
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country
  • 4.4.4. Administration sets Intravenous Equipment Market by Type of set
• 4.5. Needleless connectors
  • 4.5.1. Key market trends, growth factors and opportunities
  • 4.5.2. Market size and forecast, by region
  • 4.5.3. Market share analysis by country
• 4.6. Others
  • 4.6.1. Key market trends, growth factors and opportunities
  • 4.6.2. Market size and forecast, by region
  • 4.6.3. Market share analysis by country

CHAPTER 5: INTRAVENOUS EQUIPMENT MARKET, BY END USER

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Hospitals and clinics
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Homecare settings
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Others
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country

CHAPTER 6: INTRAVENOUS EQUIPMENT MARKET, BY REGION

• 6.1. Overview
  • 6.1.1. Market size and forecast By Region
• 6.2. North America
  • 6.2.1. Key trends and opportunities
  • 6.2.2. Market size and forecast, by Product Type
  • 6.2.3. Market size and forecast, by End User
  • 6.2.4. Market size and forecast, by country
    • 6.2.4.1. U.S.
    • 6.2.4.1.1. Key market trends, growth factors and opportunities
    • 6.2.4.1.2. Market size and forecast, by Product Type
    • 6.2.4.1.3. Market size and forecast, by End User
    • 6.2.4.2. Canada
    • 6.2.4.2.1. Key market trends, growth factors and opportunities
    • 6.2.4.2.2. Market size and forecast, by Product Type
    • 6.2.4.2.3. Market size and forecast, by End User
    • 6.2.4.3. Mexico
    • 6.2.4.3.1. Key market trends, growth factors and opportunities
    • 6.2.4.3.2. Market size and forecast, by Product Type
    • 6.2.4.3.3. Market size and forecast, by End User
• 6.3. Europe
  • 6.3.1. Key trends and opportunities
  • 6.3.2. Market size and forecast, by Product Type
  • 6.3.3. Market size and forecast, by End User
  • 6.3.4. Market size and forecast, by country
    • 6.3.4.1. Germany
    • 6.3.4.1.1. Key market trends, growth factors and opportunities
    • 6.3.4.1.2. Market size and forecast, by Product Type
    • 6.3.4.1.3. Market size and forecast, by End User
    • 6.3.4.2. France
    • 6.3.4.2.1. Key market trends, growth factors and opportunities
    • 6.3.4.2.2. Market size and forecast, by Product Type
    • 6.3.4.2.3. Market size and forecast, by End User
    • 6.3.4.3. UK
    • 6.3.4.3.1. Key market trends, growth factors and opportunities
    • 6.3.4.3.2. Market size and forecast, by Product Type
    • 6.3.4.3.3. Market size and forecast, by End User
    • 6.3.4.4. Italy
    • 6.3.4.4.1. Key market trends, growth factors and opportunities
    • 6.3.4.4.2. Market size and forecast, by Product Type
    • 6.3.4.4.3. Market size and forecast, by End User
    • 6.3.4.5. Spain
    • 6.3.4.5.1. Key market trends, growth factors and opportunities
    • 6.3.4.5.2. Market size and forecast, by Product Type
    • 6.3.4.5.3. Market size and forecast, by End User
    • 6.3.4.6. Rest of Europe
    • 6.3.4.6.1. Key market trends, growth factors and opportunities
    • 6.3.4.6.2. Market size and forecast, by Product Type
    • 6.3.4.6.3. Market size and forecast, by End User
• 6.4. Asia-Pacific
  • 6.4.1. Key trends and opportunities
  • 6.4.2. Market size and forecast, by Product Type
  • 6.4.3. Market size and forecast, by End User
  • 6.4.4. Market size and forecast, by country
    • 6.4.4.1. Japan
    • 6.4.4.1.1. Key market trends, growth factors and opportunities
    • 6.4.4.1.2. Market size and forecast, by Product Type
    • 6.4.4.1.3. Market size and forecast, by End User
    • 6.4.4.2. China
    • 6.4.4.2.1. Key market trends, growth factors and opportunities
    • 6.4.4.2.2. Market size and forecast, by Product Type
    • 6.4.4.2.3. Market size and forecast, by End User
    • 6.4.4.3. India
    • 6.4.4.3.1. Key market trends, growth factors and opportunities
    • 6.4.4.3.2. Market size and forecast, by Product Type
    • 6.4.4.3.3. Market size and forecast, by End User
    • 6.4.4.4. Australia
    • 6.4.4.4.1. Key market trends, growth factors and opportunities
    • 6.4.4.4.2. Market size and forecast, by Product Type
    • 6.4.4.4.3. Market size and forecast, by End User
    • 6.4.4.5. South Korea
    • 6.4.4.5.1. Key market trends, growth factors and opportunities
    • 6.4.4.5.2. Market size and forecast, by Product Type
    • 6.4.4.5.3. Market size and forecast, by End User
    • 6.4.4.6. Rest of Asia-Pacific
    • 6.4.4.6.1. Key market trends, growth factors and opportunities
    • 6.4.4.6.2. Market size and forecast, by Product Type
    • 6.4.4.6.3. Market size and forecast, by End User
• 6.5. LAMEA
  • 6.5.1. Key trends and opportunities
  • 6.5.2. Market size and forecast, by Product Type
  • 6.5.3. Market size and forecast, by End User
  • 6.5.4. Market size and forecast, by country
    • 6.5.4.1. Brazil
    • 6.5.4.1.1. Key market trends, growth factors and opportunities
    • 6.5.4.1.2. Market size and forecast, by Product Type
    • 6.5.4.1.3. Market size and forecast, by End User
    • 6.5.4.2. Saudi Arabia
    • 6.5.4.2.1. Key market trends, growth factors and opportunities
    • 6.5.4.2.2. Market size and forecast, by Product Type
    • 6.5.4.2.3. Market size and forecast, by End User
    • 6.5.4.3. South Africa
    • 6.5.4.3.1. Key market trends, growth factors and opportunities
    • 6.5.4.3.2. Market size and forecast, by Product Type
    • 6.5.4.3.3. Market size and forecast, by End User
    • 6.5.4.4. Rest of LAMEA
    • 6.5.4.4.1. Key market trends, growth factors and opportunities
    • 6.5.4.4.2. Market size and forecast, by Product Type
    • 6.5.4.4.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

• 8.1. Becton, Dickinson and Company
  • 8.1.1. Company overview
  • 8.1.2. Key Executives
  • 8.1.3. Company snapshot
  • 8.1.4. Operating business segments
  • 8.1.5. Product portfolio
  • 8.1.6. Business performance
• 8.2. B. Braun SE
  • 8.2.1. Company overview
  • 8.2.2. Key Executives
  • 8.2.3. Company snapshot
  • 8.2.4. Operating business segments
  • 8.2.5. Product portfolio
  • 8.2.6. Business performance
• 8.3. ICU Medical, Inc.
  • 8.3.1. Company overview
  • 8.3.2. Key Executives
  • 8.3.3. Company snapshot
  • 8.3.4. Operating business segments
  • 8.3.5. Product portfolio
  • 8.3.6. Business performance
  • 8.3.7. Key strategic moves and developments
• 8.4. Baxter International Inc.
  • 8.4.1. Company overview
  • 8.4.2. Key Executives
  • 8.4.3. Company snapshot
  • 8.4.4. Operating business segments
  • 8.4.5. Product portfolio
  • 8.4.6. Business performance
  • 8.4.7. Key strategic moves and developments
• 8.5. Teleflex Incorporated.
  • 8.5.1. Company overview
  • 8.5.2. Key Executives
  • 8.5.3. Company snapshot
  • 8.5.4. Operating business segments
  • 8.5.5. Product portfolio
  • 8.5.6. Business performance
• 8.6. 3M Company
  • 8.6.1. Company overview
  • 8.6.2. Key Executives
  • 8.6.3. Company snapshot
  • 8.6.4. Operating business segments
  • 8.6.5. Product portfolio
  • 8.6.6. Business performance
• 8.7. AngioDynamics, Inc.
  • 8.7.1. Company overview
  • 8.7.2. Key Executives
  • 8.7.3. Company snapshot
  • 8.7.4. Operating business segments
  • 8.7.5. Product portfolio
  • 8.7.6. Business performance
• 8.8. Terumo Corporation
  • 8.8.1. Company overview
  • 8.8.2. Key Executives
  • 8.8.3. Company snapshot
  • 8.8.4. Operating business segments
  • 8.8.5. Product portfolio
  • 8.8.6. Business performance
• 8.9. Poly Medicure Ltd.
  • 8.9.1. Company overview
  • 8.9.2. Key Executives
  • 8.9.3. Company snapshot
  • 8.9.4. Operating business segments
  • 8.9.5. Product portfolio
  • 8.9.6. Business performance
• 8.10. Vygon
  • 8.10.1. Company overview
  • 8.10.2. Key Executives
  • 8.10.3. Company snapshot
  • 8.10.4. Operating business segments
  • 8.10.5. Product portfolio